(Q37689793)

22 August 2017

title

Therapeutic potential of adenosine receptor antagonists and agonists (English)

1 reference

22 August 2017

Neil J Press

1

1 reference

22 August 2017

Stefania Gessi

series ordinal

2

1 reference

22 August 2017

Pier A Borea

series ordinal

3

1 reference

22 August 2017

Riccardo Polosa

series ordinal

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Expert Opinion on Therapeutic Patents

22 August 2017

published in

1 reference

22 August 2017

volume

17

1 reference

22 August 2017

issue

8

1 reference

22 August 2017

page(s)

979-991

1 reference

The cardiac effects of adenosine

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

How does adenosine inhibit transmitter release?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Heterotrimeric G protein-independent signaling of a G protein-coupled receptor. Direct binding of ARNO/cytohesin-2 to the carboxyl terminus of the A2A adenosine receptor is necessary for sustained activation of the ERK/MAP kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Rescue of p53 blockage by the A(2A) adenosine receptor via a novel interacting protein, translin-associated protein X

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Adenosine in tissue protection and tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Adenosine receptors as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

IB-MECA and cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

A3 adenosine receptor-mediated protection of the ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Growth regulation of the vascular system: an emerging role for adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Adenosine receptors: promising targets for the development of novel therapeutics and diagnostics for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Adenosine A2B receptors: a novel therapeutic target in asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

A glance at adenosine receptors: novel target for antitumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Adenosine receptors in the response to sepsis: what do receptor-specific knockouts tell us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

The cross-species A3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

A novel partial agonist of the A(1)-adenosine receptor and evidence of receptor homogeneity in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow-derived cells or deletion of the A2A receptor on non-bone marrow-derived cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Impact of selective adenosine A2A receptor agonists on cardiac imaging feeling the lightning, waiting on the thunder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

The future of pharmacologic stress: selective A2A adenosine receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A2A receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

A3-adenosine receptors: design of selective ligands and therapeutic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.8.979

10.1517/13543776.17.8.979

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference